ORIGINAL PAPER
Correlation between double-stranded DNA and rheumatoid arthritis
More details
Hide details
1
School of Basic Medicine, North China University of Science and Technology, Tangshan, Hebei, 063210, China
2
Hebei Key Laboratory for Chronic Diseases, School of Basic Medicine, North China University of Science and Technology, Tangshan, Hebei, 063210, China
3
North China University of Science and Technology Affiliated Hospital, Tangshan, 063000, China
4
School of Public Health, North China University of Science and Technology, Tangshan, Hebei, 063210, China
5
School of Clinical Medicine, North China University of Science and Technology, Tangshan, Hebei, 063210, China
6
North China University of Science and Technology, Tangshan, Hebei, 063210, China
7
Hebei Key Laboratory of Medical Engineering and Integrated Utilization of Saline-Alkali Land, Tangshan, Hebei, 063210, China
8
Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China
These authors had equal contribution to this work
Submission date: 2024-11-24
Final revision date: 2025-04-06
Acceptance date: 2025-04-08
Online publication date: 2026-01-27
Corresponding author
Liangdan Sun
North China University of Science and Technology, Tangshan, Hebei, 063210, China
KEYWORDS
ABSTRACT
Introduction:
Rheumatoid arthritis (RA) is a chronic autoimmune disease influenced by environmental factors. Double-stranded DNA (dsDNA) serves as an antigen in various autoimmune diseases and is affected by meteorological factors. However, the relationships among the circulating dsDNA level, RA inflammatory immune mechanisms, and seasonal meteorological factors remain unclear.
Material and Methods:
Serum dsDNA levels were measured in patients with RA and healthy controls, and correlations with archived data on seasonal meteorological changes were examined. Quantitative PCR was performed to assess the gene expression of relevant receptor markers in the peripheral circulation of patients and controls.
Results:
The mean serum dsDNA level was significantly higher in patients with RA than in controls (1.16 ±0.36 ng/ml vs. 0.92 ±0.20 ng/ml, p < 0.001). The expression of genes related to dsDNA receptors, single-stranded RNA receptors, dsRNA receptors, ALR inflammasome-associated inflammatory factors, interferon (IFN) 1, IFN1, and low-density lipoprotein was upregulated in patients with RA.
Conclusions:
dsDNA levels in the peripheral circulation of patients with RA are elevated and affected by seasonal climatic factors. This elevation enhances the expression of ALR inflammasome-related inflammatory factors and type I IFN. These findings provide a foundation for future investigations into the mechanisms underlying the link between climate variability and RA progression.
REFERENCES (48)
1.
Jiang L, Shang M, Yu S, et al. (2022): A high-fiber diet synergizes with Prevotella copri and exacerbates rheumatoid arthritis. Cell Mol Immunol 19: 1414-1424.
2.
Yokota K, Sato K, Miyazaki T, et al. (2021): Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis. Arthritis Rheumatol 73: 1145-1154.
3.
Almutairi K, Nossent J, Preen D, et al. (2021): The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 41: 863-877.
4.
Chen H, Fu X, Wu X, et al. (2024): Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis. Bone Res 12: 31.
5.
Szeto CC, Mok HY, Chow KM, et al. (2008): Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong. J Rheumatol 35: 1031-1037.
6.
Duarte-Garcia A, Fang H, To CH, et al. (2012): Seasonal variation in the activity of systemic lupus erythematosus. J Rheumatol 39: 1392-1398.
7.
van Setten G, Labetoulle M, Baudouin C, Rolando M (2016): Evidence of seasonality and effects of psychrometry in dry eye disease. Acta Ophthalmol 94: 499-506.
8.
Jacoby RK, Jayson MI, Cosh JA (1973): Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J 2: 96-100.
9.
Akerblom A, Helmersson-Karlqvist J, Weitoft T, Larsson A (2017): Seasonal variations of urate in a Swedish adult population. Clin Rheumatol 36: 1595-1598.
10.
Han Y, Sheng Q, Fang Y (2022): Exploring the spatial distribution of rheumatic diseases and its correlation with temperature and humidity among middle-aged and elderly adults in China. Int J Public Health 67: 1604782.
11.
Ferreira ML, Zhang Y, Metcalf B, et al. (2016): The influence of weather on the risk of pain exacerbation in patients with knee osteoarthritis – a case-crossover study. Osteoarthritis Cartilage 24: 2042-2047.
12.
Strusberg I, Mendelberg RC, Serra HA, Strusberg AM (2002): Influence of weather conditions on rheumatic pain. J Rheumatol 29: 335-338.
13.
Abasolo L, Tobías A, Leon L, et al. (2013): Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. Reumatol Clin 9: 226-228.
14.
Zeng P, Bengtsson C, Klareskog L, Alfredsson L (2017): Working in cold environment and risk of developing rheumatoid arthritis: results from the Swedish EIRA case-control study. RMD Open 3: e000488.
15.
Huang LJ, Zha JJ, Cao NW, et al. (2022): Temperature might increase the hospital admission risk for rheumatoid arthritis patients in Anqing, China: a time-series study. Int J Biometeorol 66: 201-211.
16.
Wang J, Yu L, Deng J, et al. (2022): Short-term effect of meteorological factors on the risk of rheumatoid arthritis hospital admissions: A distributed lag non-linear analysis in Hefei, China. Environ Res 207: 112168.
17.
de Rooy DP, Andersson MLE, Knevel R, et al. (2012): Does the season at symptom onset influence the long-term severity of radiographic joint destruction in rheumatoid arthritis? Ann Rheum Dis 71: 2055-2056.
18.
Arkema EV, Hart JE, Bertrand KA, et al. (2013): Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses’ Health Study. Ann Rheum Dis 72: 506-511.
19.
McGrath H, Jr., Smith JL, Bak E, Michalski JP (1987): Ultraviolet-A light in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 5: 323-328.
20.
Atamaniuk J, Hsiao YY, Mustak M, et al. (2011): Analysing cell-free plasma DNA and SLE disease activity. Eur J Clin Invest 41: 579-583.
21.
Bartoloni E, Ludovini V, Alunno A, et al. (2011): Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren’s syndrome. Lupus 20: 928-935.
22.
Mosca M, Giuliano T, Cuomo G, et al. (2009): Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol 28: 1437-1440.
23.
Hajizadeh S, DeGroot J, TeKoppele JM, et al. (2003): Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 5: R234-240.
24.
Derksen V, Huizinga TWJ, van der Woude D (2017): The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39: 437-446.
25.
Bronkhorst AJ, Wentzel JF, Aucamp J, et al. (2016): Characterization of the cell-free DNA released by cultured cancer cells. Biochim Biophys Acta 1863: 157-165.
26.
Hatterer E, Shang L, Simonet P, et al. (2016): A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease. Arthritis Res Ther 18: 224.
27.
Jovasevic V, Wood EM, Cicvaric A, et al. (2024): Formation of memory assemblies through the DNA-sensing TLR9 pathway. Nature 628: 145-153.
28.
Means TK, Latz E, Hayashi F, et al. (2005): Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407-417.
29.
Honda K, Takaoka A, Taniguchi T (2006): Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
30.
Atianand MK, Rathinam VA, Fitzgerald KA (2013): SnapShot: inflammasomes. Cell 153: 272-272.e271.
31.
Yang M, Long D, Hu L, et al. (2021): AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther 6: 341.
32.
Liu Z, Han C, Fu YX (2020): Targeting innate sensing in the tumor microenvironment to improve immunotherapy. Cell Mol Immunol 17: 13-26.
33.
Guo H, Callaway JB, Ting J (2015): Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21: 677-687.
34.
Shimada K, Crother TR, Karlin J, et al. (2012): Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401-414.
35.
Wang Y, Ning X, Gao P, et al. (2017): Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection. Immunity 46: 393-404.
36.
Banerjee I, Behl B, Mendonca M, et al. (2018): Gasdermin D restrains type I interferon response to cytosolic DNA by disrupting ionic homeostasis. Immunity 49: 413-426.e5.
37.
Zhou YX, Wei J, Deng G, et al. (2023): Delivery of low-density lipoprotein from endocytic carriers to mitochondria supports steroidogenesis. Nat Cell Biol 25: 937-949.
38.
Boren J, Chapman MJ, Krauss RM, et al. (2020): Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41: 2313-2330.
39.
Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, et al. (2012): Lipid-related markers and cardiovascular disease prediction. JAMA 307: 2499-2506.
40.
Mortensen MB, Jensen JM, Sand NPR, et al. (2024): Association of autoimmune diseases with coronary atherosclerosis severity and ischemic events. J Am Coll Cardiol 83: 2643-2654.
41.
Sharma BR, Kanneganti TD (2021): NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 22: 550-559.
42.
Fleming A, Crown JM, Corbett M (1976): Early rheumatoid disease. I. Onset. Ann Rheum Dis 35: 357-360.
43.
Mori H, Sawada T, Hishiyama S, et al. (2019): Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis. BMC Musculoskelet Disord 20: 30.
44.
Rozin A, Balbir-Gurman A, Schapira D (2003): Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropathy: the possible effect of the solar factor. Clin Exp Rheumatol 21: 161-169.
45.
Fouani M, Basset CA, Mangano GD, et al. (2022): Heat shock proteins alterations in rheumatoid arthritis. Int J Mol Sci 23: 2806.
46.
Mantej J, Polasik K, Piotrowska E, Tukaj S (2019): Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis. Cell Stress Chaperones 24: 283-287.
47.
Holick MF (2007): Vitamin D deficiency. N Engl J Med 357: 266-281.
48.
Lin J, Liu J, Davies ML, Chen W (2016): Serum vitamin D level and rheumatoid arthritis disease activity: Review and meta-analysis. PLoS One 11: e0146351.